EC opinion deems HMO safe to place on market as Novel Food
European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE
Comments Off on EC opinion deems HMO safe to place on market as Novel Food
April 6, 2020